NOV 01, 2023 8:00 AM PDT

DONT USEAccelerating Your Adoptive Cell Therapy Clinical Trial Timelines with Comprehensive Biomarker-driven strategies

Sponsored by: Labcorp Oncology
Speakers

Abstract
In this roundtable, our panel of scientists will highlight the adoption of biomarker strategies that can create efficiency in your clinical cell therapy development efforts. Specific areas of focus include:
  • Applying a precision medicine biomarker-driven strategy that takes into account specified context of use and its evolution as your development progresses 
  • Flow cytometry applications for the development of ACTs
  • Analytical tools to assess CRS, neurotoxicity and unintended/intended events for deployment and long-term follow-up of adoptive cell therapies
  • Comprehensive immune profiling applications including NGS, TCR β repertoire, and HLA haplotype to support translational research studies

 

Webinars will be available for unlimited on-demand viewing after live event.

 


You May Also Like
Loading Comments...
Attendees